Distraction Laminoplasty with Interlaminar Lumbar Instrumented Fusion (ILIF) for Lumbar Stenosis with or Without Grade 1 Spondylolisthesis

Cuéllar, Jason M.; Field, Justin; Bae, Hyun W.

doi:10.1097/brs.0000000000001484

Cited by 5 publications

(12 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The results obtained at the end of Phase II of the study (36-m after surgery) indicated the efficacy of spinal fixation using percutaneous screw and rod spinal fixation, alone or as a part of the 3-in-1 procedure for management of FBSS patients as evidenced by the maintained significant reduction of pain and disability scores till 36-m PO in comparison to preoperative scores. These findings supported the previous studies that documented the long-term improvement of ODI and pain scores after instrumented fusion of FBSS patients [31][32][33][34][35]. The 3-in-1 procedure maintained significantly lower ODI and pain scores in comparison to preoperative scores and to the 36-m scores of patients had PSRF only.…”

Section: Discussionsupporting

confidence: 90%

Three-in-one procedure for failed spinal surgery improved pain, disability scores and serum inflammatory milieu: Three-years follow-up

Hamdy

Salem

2021

Egyptian Journal of Anaesthesia

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 90%

Three-in-one procedure for failed spinal surgery improved pain, disability scores and serum inflammatory milieu: Three-years follow-up

Hamdy

Salem

2021

Egyptian Journal of Anaesthesia

View full text Add to dashboard Cite

show abstract

“…Cuellar et al performed a prospective multicenter study evaluating interlaminar lumbar instrumented fusion, which is a subtype of ISF. 104 Thirty-seven patients with single level degenerative lumbar stenosis were treated with lumbar decompression using a laminoplasty procedure followed by insertion of an allograft bone block and interspinous stabilization/fixation device. Follow-up was up to 24 months; 33 patients met the endpoint criteria (ODI and ZCQ) at 2 years.…”

Section: Interspinous Fusionmentioning

confidence: 99%

“…Another multicenter, RCT compared ISF with decompression to decompression with pedicle screw fusion. 104 Subjects with moderate-to-severe lumbar stenosis were included and followed for 5 years. Composite endpoints included ODI, repeat surgery, further lumbar injections, or adverse events.…”

Section: Interspinous Fusionmentioning

confidence: 99%

Best Practices for Minimally Invasive Lumbar Spinal Stenosis Treatment 2.0 (MIST): Consensus Guidance from the American Society of Pain and Neuroscience (ASPN)

Deer¹,

Grider²,

Pope³

et al. 2022

JPR

View full text Add to dashboard Cite

Introduction Lumbar spinal stenosis (LSS) is a common spinal disease of aging with a growing patient population, paralleling population growth. Minimally invasive treatments are evolving, and the use of these techniques needs guidance to provide the optimal patient safety and efficacy outcomes. Methods The American Society of Pain and Neuroscience (ASPN) identified an educational need for guidance on the prudent use of the innovative minimally invasive surgical therapies for the treatment of symptomatic LSS. The executive board nominated experts spanning anesthesiology, physiatry, orthopedic surgery, and neurosurgery based on expertise, publications, research, diversity and field of practice. Evidence was reviewed, graded using the United States Preventive Services Task Force (USPSTF) criteria for evidence and recommendation strength and grade, and expert opinion was added to make consensus points for best practice. Results The world literature in English was searched using Medline, EMBASE, Cochrane CENTRAL, BioMed Central, Web of Science, Google Scholar, PubMed, Current Contents Connect, Scopus, and meeting abstracts to identify and compile the evidence (per section) for LSS-related pain. Search words were selected based upon the section represented. Identified peer-reviewed literature was critiqued using USPSTF criteria and consensus points are presented. Discussion The algorithm for patient selection in the management of symptomatic spinal stenosis is evolving. Careful consideration of patient selection and anatomic architecture variance is critical for improved outcomes and patient safety. Conclusion ASPN created a guidance for best practice for minimally invasive surgical treatment of symptomatic spinal stenosis.

show abstract

“…com/CJP/A846), while 32 (9.7%) reported that they tracked opioid use. However, of these 32, only 21 studies (6.4% of all studies) 41,[43][44][45][46][47]49,52,53,[56][57][58][60][61][62][63]65,[69][70][71][72] specifically reported opioid use out to at least 6 months (Table 2). Eleven of the 329 studies 42,48,50,51,54,55,59,64,[66][67][68] tracked opioid use before surgery or immediately after surgery but did not track opioids out at least 6 months.…”

Section: Characteristics Of Included Studiesmentioning

confidence: 99%

More Than 1 in 3 Patients With Chronic Low Back Pain Continue to Use Opioids Long-term After Spinal Fusion

Vraa

Myers

Young

et al. 2021

The Clinical Journal of Pain

View full text Add to dashboard Cite

Objective: A common expectation for patients after elective spine surgery is that the procedure will result in pain reduction and minimize the need for pain medication. Most studies report changes in pain and function after spine surgery, but few report the extent of opioid use after surgery. This systematic review aims to identify the rates of opioid use after lumbar spine fusion.Materials and Methods: PubMed, CINAHL, Cochrane Central Register of Controlled Trials, and Ovid Medline were searched to identify studies published between January 1, 2005 and June 30, 2020 that assessed the effectiveness of lumbar fusion for the management of low back pain.Results: Of 6872 abstracts initially identified, 329 studies met the final inclusion criteria, and only 32 (9.7%) reported any postoperative opioid use. Long-term opioid use after surgery persists for more than 1 in 3 patients with usage ranging from 6 to 85.9% and a pooled mean of 35.0% based on data from 21 studies (6.4% of all lumbar fusion studies).Discussion: Overall, opioid use is not reported in the majority of lumbar fusion trials. Patients may expect a reduced need for opioidbased pain management after surgery, but the limited data available suggests long-term use is common. Lack of consistent reporting of these outcomes limits definitive conclusions regarding the efficacy of spinal fusion for reducing long-term opioid. Patient decisions about undergoing surgery may be altered if they had realistic expectations about rates of postsurgical opioid use. Spine surgery trials should track opioid utilization out to a minimum of 6 months after surgery as a core outcome.

show abstract

Distraction Laminoplasty with Interlaminar Lumbar Instrumented Fusion (ILIF) for Lumbar Stenosis with or Without Grade 1 Spondylolisthesis

Abstract: NA.

Cited by 5 publications

References 0 publications

Three-in-one procedure for failed spinal surgery improved pain, disability scores and serum inflammatory milieu: Three-years follow-up

Three-in-one procedure for failed spinal surgery improved pain, disability scores and serum inflammatory milieu: Three-years follow-up

Best Practices for Minimally Invasive Lumbar Spinal Stenosis Treatment 2.0 (MIST): Consensus Guidance from the American Society of Pain and Neuroscience (ASPN)

More Than 1 in 3 Patients With Chronic Low Back Pain Continue to Use Opioids Long-term After Spinal Fusion

Contact Info

Product

Resources

About